120 (OR = 3.3, CI = 1.14-9.7), Cross Clamp time>80 min (OR = 4.16, CI = 1.73-9.98) and IABP insertion postoperatively (OR = 19.19, CI = 3.16-116.47). The incremental risk factors for the development of complications were: Poor EF (OR = 3.16, CI = 0.87-11.52), Euroscore >7 (OR = 2.99, CI = 1.14-7.88), history of PVD (OR = 4.99, CI = 1.32-18.86). The 5 years survival was 79.2% for the CABG population and 71.5% for the valve group. (Hazard ratio = 1.78, CI = 0.92-3.46). Conclusions IABP represents a safe option of supporting the failing heart. The need for IABP especially in a high risk Valve population is associated with early unfavourable outcome, however the positive mid term results further justify its use."/>
Status | O.R. | 95% C.I. | |||||
---|---|---|---|---|---|---|---|
Risk factor | alive | dead | p value | ||||
Gender | male | 65 | 32 | 1.00 | |||
female | 20 | 15 | 3.87 | 1.30 | 11.6 | 0.015 | |
Smoking | No | 33 | 9 | 1.00 | |||
Yes | 13 | 10 | 4.88 | 1.23 | 19.37 | 0.024 | |
Ex | 39 | 28 | 3.62 | 1.20 | 10.98 | 0.023 | |
Pre Op Creatinine | <=120 | 70 | 32 | 1.00 | |||
>120 | 15 | 15 | 3.33 | 1.14 | 9.70 | 0.027 | |
Cross Clamp Time | <=80 | 66 | 22 | 1.00 | |||
>80 | 19 | 25 | 4.16 | 1.73 | 9.98 | 0.001 | |
IABP | pre op | 16 | 4 | 1.00 | |||
intra op | 59 | 29 | 4.27 | 0.95 | 19.15 | 0.058 | |
post op | 10 | 14 | 19.19 | 3.16 | 116.47 | 0.001 |